Exactus Inc. (EXDI)
| Market Cap | 8.91M |
| Revenue (ttm) | 2.07M |
| Net Income (ttm) | -9.46M |
| Shares Out | 53.21M |
| EPS (ttm) | -0.25 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 16 |
| Last Price | $0.1675 |
| Previous Close | $0.1700 |
| Change ($) | -0.0025 |
| Change (%) | -1.47% |
| Day's Open | 0.1511 |
| Day's Range | 0.1500 - 0.1675 |
| Day's Volume | 76,871 |
| 52-Week Range | 0.0400 - 0.3200 |
News
There are no news available yet.
About EXDI
Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactu... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| Stock Exchange OTCMKTS | Ticker Symbol EXDI |
Financial Performance
In 2020, Exactus's revenue was $2.07 million, an increase of 499.11% compared to the previous year's $345,680. Losses were -$9.46 million, -0.22% less than in 2019.